Back to User profile » Professor Dave Singh

Papers published by Professor Dave Singh:


CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care

Pullen R, Miravitlles M, Sharma A, Singh D, Martinez F, Hurst JR, Alves L, Dransfield M, Chen R, Muro S, Winders T, Blango C, Muellerova H, Trudo F, Dorinsky P, Alacqua M, Morris T, Carter V, Couper A, Jones R, Kostikas K, Murray R, Price DB

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2301-2322

Published Date: 12 August 2021

A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD

Ming SWY, Haughney J, Ryan D, Small I, Lavorini F, Papi A, Singh D, Halpin DMG, Hurst JR, Patel S, Ochel M, Kocks J, Carter V, Hardjojo A, Price DB

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:3093-3103

Published Date: 26 November 2020

Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD: A Historical Real-World Non-Inferiority Study

Voorham J, Baldi S, Santoro L, Kerkhof M, Contoli M, Fabbri LM, Kerstjens HAM, Luis López-Campos J, Roche N, Singh D, Vogelmeier CF, Price DB

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2739-2750

Published Date: 29 October 2020

An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD

Singh D, D'Urzo AD, Donohue JF, Kerwin EM, Molins E, Chuecos F, Ribera A, Jarreta D

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2835-2848

Published Date: 6 December 2019

Reproducibility of nasal allergen challenge responses in adults with allergic rhinitis

Pantin CT, Southworth T, Wetzel K, Singh D

Clinical Pharmacology: Advances and Applications 2019, 11:67-76

Published Date: 13 May 2019

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA

Singh D, Fabbri LM, Vezzoli S, Petruzzelli S, Papi A

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:531-546

Published Date: 28 February 2019

Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT

D'Urzo AD, Singh D, Donohue JF, Kerwin EM, Ribera A, Molins E, Chuecos F, Jarreta D, Garcia Gil E

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:479-491

Published Date: 26 February 2019

Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East-North Africa region, 2017 [Corrigendum]

Mahboub BH, Vats MG, Al Zaabi A, Iqbal MN, Safwat T, Al-Hurish F, Miravitlles M, Singh D, Asad K, Zeineldine S, Al Hajjaj MS

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:115-116

Published Date: 18 January 2019

Effects of baseline symptom burden on treatment response in COPD

Martinez FJ, Abrahams RA, Ferguson GT, Bjermer L, Grönke L, Voß F, Singh D

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:181-194

Published Date: 4 January 2019

The Manchester Respiratory-related Sleep Symptoms scale for patients with COPD: development and validation

Khan N, Vestbo J, Garrow A, Karur P, Kolsum U, Tyson S, Singh D, Yorke J

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3885-3894

Published Date: 29 November 2018

Feasibility and challenges of using multiple breath washout in COPD

Bell AS, Lawrence PJ, Singh D, Horsley A

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2113-2119

Published Date: 10 July 2018

Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells

Higham A, Karur P, Jackson N, Cunoosamy DM, Jansson P, Singh D

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1279-1288

Published Date: 19 April 2018

The effects of repeated Toll-like receptors 2 and 4 stimulation in COPD alveolar macrophages

Lea SR, Reynolds SL, Kaur M, Simpson KD, Hall SR, Hessel EM, Singh D

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:771-780

Published Date: 2 March 2018

CRTH2 antagonists in asthma: current perspectives

Singh D, Ravi A, Southworth T

Clinical Pharmacology: Advances and Applications 2017, 9:165-173

Published Date: 15 December 2017

Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East–North Africa region, 2017

Mahboub BH, Vats MG, Al Zaabi A, Iqbal MN, Safwat T, Al-Hurish F, Miravitlles M, Singh D, Asad K, Zeineldine S, Al-Hajjaj MS

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2869-2890

Published Date: 9 October 2017

Perception of symptoms and quality of life – comparison of patients’ and physicians’ views in the COPD MIRROR study

Celli B, Blasi F, Gaga M, Singh D, Vogelmeier C, Pegoraro V, Caputo N, Agusti A

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2189-2196

Published Date: 27 July 2017

Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 study

Singh D, Scuri M, Collarini S, Vezzoli S, Mariotti F, Muraro A, Acerbi D

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2001-2014

Published Date: 7 July 2017

Clinical characteristics of COPD patients with tidal expiratory flow limitation

Dean J, Kolsum U, Hitchen P, Gupta V, Singh D

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1503-1506

Published Date: 22 May 2017

Ampicillin resistance in Haemophilus influenzae from COPD patients in the UK

Maddi S, Kolsum U, Jackson S, Barraclough R, Maschera B, Simpson KD, Pascal TG, Durviaux S, Hessel EM, Singh D

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1507-1518

Published Date: 22 May 2017

LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis

Rodrigo GJ, Price D, Anzueto A, Singh D, Altman P, Bader G, Patalano F, Fogel R, Kostikas K

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:907-922

Published Date: 17 March 2017

Characterization of TLR-induced inflammatory responses in COPD and control lung tissue explants

Pomerenke A, Lea SR, Herrick S, Lindsay MA, Singh D

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2409-2417

Published Date: 29 September 2016

Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controls

Lea SR, Metcalfe HJ, Plumb J, Beerli C, Poll C, Singh D, Abbott-Banner KH

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2139-2147

Published Date: 6 September 2016

Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol

Singh D, Maleki-Yazdi MR, Tombs L, Iqbal A, Fahy WA, Naya I

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:1413-1424

Published Date: 24 June 2016

Safety of indacaterol in the treatment of patients with COPD

Donohue JF, Singh D, Kornmann O, Lawrence D, Lassen C, Kramer B

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:477-492

Published Date: 22 September 2011